Skip to content

Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigma

Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigma

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05149001
Acronym
RESILSTIGMA
Enrollment
667
Registered
2021-12-08
Start date
2022-01-17
Completion date
2022-04-14
Last updated
2026-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

HIV, Stigmatization, Self-stigma

Brief summary

This study is perform to study the effect of psychological and psychosocial factors associated with resilience to the self-stigmatization of people living with HIV

Detailed description

Epidemiological and sociological survey carried out with patients and their caregivers in the CHUs and CHGs of France via the COREVIH from 01/17/2022 to 02/17/2022. Primary endpoint: Self-stigmatization as experienced by PLWHA will be explored through a patient questionnaire Secondary endpoints:The main explanatory variables will be studied by means of a custom questionnaire intended for the patient and covering psychological flexibility, social provisions, avoidance and fusion mechanisms, quality of life, anxiety and depression. The socio-demographic explanatory variables will be collected by questionnaire, covering the following areas: sex, age, geographical origin, insecurity, drug use, sexuality, family context, employment, leisure, care environment. A questionnaire intended for caregivers will study the self-stigmatization perception of the people they care for and the means implemented to fight against self-stigmatization. Anonymous data will be reported in Redcap. The population will be described by numbers and percentages for categorical variables and by the mean ± standard deviation or the median \[interquartile range\] for the quantitative variables, with regard to their statistical distribution. Normality will be studied by the Shapiro-Wilk test and / or by histogram. As far as possible, graphical representations will be associated with the analyzes.

Interventions

None listed

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER
Poitiers University Hospital
CollaboratorOTHER
Poissy-Saint Germain Hospital
CollaboratorOTHER
Centre Hospitalier Universitaire Dijon
CollaboratorOTHER
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
CollaboratorOTHER
Hopital Antoine Beclere
CollaboratorOTHER
Nantes University Hospital
CollaboratorOTHER
Hospital, La Roche sur Yon
CollaboratorUNKNOWN
Hôpital Necker-Enfants Malades
CollaboratorOTHER
Centre Hospitalier de Bretagne Sud
CollaboratorOTHER
Reims University hospital
CollaboratorOTHER
Groupe Hospitalier de la Rochelle Ré Aunis
CollaboratorOTHER
Hospital Laennec, Quimper
CollaboratorUNKNOWN
University Hospital, Brest
CollaboratorOTHER
Hospital Cornouaille, Quimper
CollaboratorUNKNOWN
Centre Hospitalier de Cholet
CollaboratorOTHER
University Hospital, Strasbourg
CollaboratorOTHER
CH Annecy Genevois
CollaboratorOTHER
Perpignan Hospital Center
CollaboratorOTHER
Centre Hospitalier le Mans
CollaboratorOTHER
Centre Hospitalier VALENCIENNES
CollaboratorOTHER
Bicetre Hospital
CollaboratorOTHER
Centre Hospitalier Universitaire de Nice
CollaboratorOTHER
University Hospital, Marseille
CollaboratorOTHER
Jacques Lacarin Hospital Center
CollaboratorOTHER
L'hôpital Nord-Ouest - Villefranche Villefranche sur Saône
CollaboratorOTHER
Centre Hospitalier Universitaire de Besancon
CollaboratorOTHER
Hospital, Vannes
CollaboratorUNKNOWN
Moulins Hospital
CollaboratorOTHER
Hospital, Montluçon
CollaboratorUNKNOWN
Centre Hospitalier de Niort
CollaboratorOTHER
Hôpital Edouard Herriot
CollaboratorOTHER
Hospital La Source, Orléans
CollaboratorUNKNOWN
Centre Hospitalier du Pays d'Aix
CollaboratorOTHER
Hospital Andre Mignot, Le Chesnay
CollaboratorUNKNOWN
Hôpital Raymond Poincaré
CollaboratorOTHER
University Hospital, Angers
CollaboratorOTHER_GOV
University Hospital, Pointe-à-Pitre
CollaboratorUNKNOWN
Centre Hospitalier des Pays de Morlaix
CollaboratorOTHER
Hospital Foch, Suresnes
CollaboratorUNKNOWN
Tenon Hospital, Paris
CollaboratorOTHER
University Hospital of Saint-Etienne
CollaboratorOTHER
Centre Hospitalier de Saint-Denis
CollaboratorOTHER
University Hospital, Mulhouse
CollaboratorUNKNOWN

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* For patients: adult patient, male or female, infected with HIV medically monitored in a hospital department involved in the investigation. * Affiliation to a Social Security scheme For caregivers:Caregiver caring for people living with HIV as part of a hospital service involved in the survey (doctor, IDE, psychologist, other ...).

Exclusion criteria

* Minor patient * Refusal of participation * Persons under guardianship, guardianship or legal protection

Design outcomes

Primary

MeasureTime frameDescription
Self-stigma as experienced by PLHIV will be explored through a custom questionnaire intended for the patient1 day during the scheduled consultation in the infectious diseases department of the Gabriel Montpied University Hospital in Clermont-FerrandPercentage of patient with self-stigma

Secondary

MeasureTime frameDescription
The main explanatory variables will be studied by means of a custom questionnaire intended for the patient1 day during the scheduled consultation in the infectious diseases department of the Gabriel Montpied University Hospital in Clermont-Ferrandmultivariate analysis of factors associated with disparition of self-stigma
Self-stigma of patients perceived by their caregivers1 day during the scheduled consultation in the infectious diseases department of the Gabriel Montpied University Hospital in Clermont-FerrandPercentage of caregivers who perceive self-stigma and how they propose to their patients the way to surpass themselves

Countries

France, Guadeloupe, Reunion

Contacts

PRINCIPAL_INVESTIGATORChristine JACOMET, Dr

University Hospital, Clermont-Ferrand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 8, 2026